Literature DB >> 19364062

Phenotypic variability in siblings with calpainopathy (LGMD2A).

J Schessl1, M C Walter, G Schreiber, U Schara, C R Müller, H Lochmüller, C G Bönnemann, R Korinthenberg, J Kirschner.   

Abstract

Calpainopathy is an autosomal-recessive limb girdle muscular dystrophy (LGMD2A) characterized by selective atrophy and weakness of proximal limb girdle muscles. The clinical phenotype of the disease is highly variable inter-familial, but little is known about intra-familial variability. This study reports the phenotypic variability in eight sibling pairs with genetically proven LGMD2A. Although siblings with identical mutations were often similarly affected, in some families the age of onset and the clinical course varied considerably.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19364062      PMCID: PMC2858935     

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  10 in total

1.  Novel mutations in the calpain 3 gene in Germany.

Authors:  A Todorova; W Kress; Cr Mueller
Journal:  Clin Genet       Date:  2005-04       Impact factor: 4.438

2.  Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.

Authors:  Markéta Hermanová; Eva Zapletalová; Jana Sedlácková; Tána Chrobáková; Ondrej Letocha; Iva Kroupová; Josef Zámecník; Petr Vondrácek; Radim Mazanec; Tatána Maríková; Stanislav Vohánka; Lenka Fajkusová
Journal:  Muscle Nerve       Date:  2006-03       Impact factor: 3.217

3.  LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.

Authors:  A Sáenz; F Leturcq; A M Cobo; J J Poza; X Ferrer; D Otaegui; P Camaño; M Urtasun; J Vílchez; E Gutiérrez-Rivas; J Emparanza; L Merlini; C Paisán; M Goicoechea; L Blázquez; B Eymard; H Lochmuller; M Walter; C Bonnemann; D Figarella-Branger; J C Kaplan; J A Urtizberea; J F Martí-Massó; A López de Munain
Journal:  Brain       Date:  2005-02-02       Impact factor: 13.501

4.  High incidence of 550delA mutation of CAPN3 in LGMD2 patients from Russia.

Authors:  T V Pogoda; I N Krakhmaleva; N A Lipatova; N I Shakhovskaya; S S Shishkin; S A Limborska
Journal:  Hum Mutat       Date:  2000-03       Impact factor: 4.878

5.  Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients.

Authors:  Michela Guglieri; Francesca Magri; Maria Grazia D'Angelo; Alessandro Prelle; Lucia Morandi; Carmelo Rodolico; Rachele Cagliani; Marina Mora; Francesco Fortunato; Andreina Bordoni; Roberto Del Bo; Serena Ghezzi; Serena Pagliarani; Sabrina Lucchiari; Sabrina Salani; Chiara Zecca; Costanza Lamperti; Dario Ronchi; Mohammed Aguennouz; Patrizia Ciscato; Claudia Di Blasi; Alessandra Ruggieri; Isabella Moroni; Anna Turconi; Antonio Toscano; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi
Journal:  Hum Mutat       Date:  2008-02       Impact factor: 4.878

6.  Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island.

Authors:  M Fardeau; D Hillaire; C Mignard; N Feingold; J Feingold; D Mignard; B de Ubeda; H Collin; F M Tome; I Richard; J Beckmann
Journal:  Brain       Date:  1996-02       Impact factor: 13.501

7.  Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families.

Authors:  A J van der Kooi; W S Frankhuizen; P G Barth; C J Howeler; G W Padberg; F Spaans; A R Wintzen; J H J Wokke; G-J B van Ommen; M de Visser; E Bakker; H B Ginjaar
Journal:  Neurology       Date:  2007-06-12       Impact factor: 9.910

8.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A.

Authors:  I Richard; O Broux; V Allamand; F Fougerousse; N Chiannilkulchai; N Bourg; L Brenguier; C Devaud; P Pasturaud; C Roudaut
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

9.  Frequency of calpain-3 c.550delA mutation in limb girdle muscular dystrophy type 2 and isolated hyperCKemia in German patients.

Authors:  F Hanisch; C R Müller; D Grimm; L Xue; K Traufeller; A Merkenschlager; S Zierz; M Deschauer
Journal:  Clin Neuropathol       Date:  2007 Jul-Aug       Impact factor: 1.368

Review 10.  Prevalence of the 550delA mutation in calpainopathy (LGMD 2A) in Croatia.

Authors:  Nina Canki-Klain; Astrid Milic; Biserka Kovac; Anuska Trlaja; Damir Grgicevic; Niko Zurak; Michel Fardeau; France Leturcq; Jean-Claude Kaplan; J Andoni Urtizberea; Luisa Politano; Giulio Piluso; Josue Feingold
Journal:  Am J Med Genet A       Date:  2004-03-01       Impact factor: 2.802

  10 in total
  6 in total

1.  Left ventricular deformation abnormalities in a patient with calpainopathy-a case from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study.

Authors:  Attila Nemes; Lívia Dézsi; Péter Domsik; Anita Kalapos; Tamás Forster; László Vécsei
Journal:  Quant Imaging Med Surg       Date:  2017-12

2.  A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.

Authors:  Debbie Hicks; Anna Sarkozy; Nuria Muelas; Katrin Köehler; Angela Huebner; Gavin Hudson; Patrick F Chinnery; Rita Barresi; Michelle Eagle; Tuomo Polvikoski; Geraldine Bailey; James Miller; Aleksander Radunovic; Paul J Hughes; Richard Roberts; Sabine Krause; Maggie C Walter; Steven H Laval; Volker Straub; Hanns Lochmüller; Kate Bushby
Journal:  Brain       Date:  2011-01       Impact factor: 13.501

3.  Mitochondrial dysfunction and consequences in calpain-3-deficient muscle.

Authors:  Vanessa E Jahnke; Jennifer M Peterson; Jack H Van Der Meulen; Jessica Boehler; Kitipong Uaesoontrachoon; Helen K Johnston; Aurelia Defour; Aditi Phadke; Qing Yu; Jyoti K Jaiswal; Kanneboyina Nagaraju
Journal:  Skelet Muscle       Date:  2020-12-11       Impact factor: 4.912

4.  Case Report: Calpainopathy Presenting After Bone Marrow Transplantation, With Studies of Donor Genetic Content in Various Tissue Types.

Authors:  Kristina Martens; Jamie Leckie; Daniel Fok; Robyn A Wells; Sameer Chhibber; Gerald Pfeffer
Journal:  Front Neurol       Date:  2021-01-11       Impact factor: 4.003

Review 5.  Current and Future Therapeutic Strategies for Limb Girdle Muscular Dystrophy Type R1: Clinical and Experimental Approaches.

Authors:  İzem Olcay Şahin; Yusuf Özkul; Munis Dündar
Journal:  Pathophysiology       Date:  2021-05-18

Review 6.  Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations.

Authors:  Jaione Lasa-Elgarresta; Laura Mosqueira-Martín; Neia Naldaiz-Gastesi; Amets Sáenz; Adolfo López de Munain; Ainara Vallejo-Illarramendi
Journal:  Int J Mol Sci       Date:  2019-09-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.